Northwest & Ethical Investments’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$708K Buy
31,019
+2,310
+8% +$56.5K 0.02% 353
2025
Q4
$653K Buy
28,709
+4,969
+21% +$108K 0.01% 367
2025
Q3
$466K Buy
+23,740
New +$398K 0.01% 405
2024
Q4
Sell
-9,420
Closed -$138K 524
2024
Q3
$138K Sell
9,420
-3,800
-29% -$52.9K ﹤0.01% 442
2024
Q2
$191K Buy
13,220
+6,300
+91% +$101K 0.01% 409
2024
Q1
$113K Buy
+6,920
New +$108K ﹤0.01% 437
2020
Q1
Sell
-22,715
Closed -$669K 372
2019
Q4
$669K Buy
22,715
+323
+1% +$8.78K 0.03% 341
2019
Q3
$595K Buy
22,392
+2,693
+14% +$80.8K 0.03% 341
2019
Q2
$666K Buy
19,699
+3,477
+21% +$113K 0.03% 337
2019
Q1
$520K Buy
16,222
+15,522
+2,217% +$478K 0.03% 343
2018
Q4
$22.1K Buy
+700
New +$22.9K ﹤0.01% 363

Other funds holding ELAN

Northwest & Ethical Investments's ELAN Position: Q1 2026 in Review

Northwest & Ethical Investments increased its Elanco Animal Health (ELAN) stake by 8% in Q1 2026, buying an estimated $56.5K and bringing the position to 31,019 shares worth $708K. The position accounts for 0.02% of the portfolio, ranked #353.

Northwest & Ethical Investments first reported a position in ELAN in Q4 2018 and has held it in 11 quarters since. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Northwest & Ethical Investments held 31,019 shares of Elanco Animal Health worth $708K as of Q1 2026.
  • Northwest & Ethical Investments bought 2,310 Elanco Animal Health shares in Q1 2026, an estimated $56.5K.
  • Elanco Animal Health made up 0.02% of Northwest & Ethical Investments's portfolio in Q1 2026, its #353 holding.
  • Northwest & Ethical Investments first reported a position in Elanco Animal Health in Q4 2018 and has held it in 11 quarters since.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.